TABLE 2:

CBF data

Measure	rCBF in ROI on 2D Displays, mL/100g/min	Mean Hemispheric CBF on 2D Displays, mL/100g/min	Area of Decreased Cortical CBF on 3D Displays, cm2
Cases*
With DIND (n = 15)	25.0 ± 5.1†	35.5 ± 5.5	22.6 ± 10.0†
Without DIND (n = 43)	37.0 ± 4.8	38.0 ± 5.3	7.4 ± 6.6
Size of infarction‡
Large (n = 5)	21.8 ± 4.3	32.6 ± 3.8	32.3 ± 6.6§
Small (n = 10)	26.6 ± 4.6	36.9 ± 5.8	17.8 ± 7.5
Prognosis at 3 mo‡
Poor (n = 6)	22.2 ± 4.2	33.7 ± 4.8	29.8 ± 7.9‖
Fair (n = 9)	26.9 ± 4.5	36.7 ± 5.8	17.8 ± 8.4

^*The CBF data obtained at the onset of DIND in the 15 DIND cases were compared with the data on routine studies in the 43 cases without DIND.

^†P < .001 compared with cases without DIND.

^‡The CBF data obtained at the onset of DIND in the 15 DIND cases were compared.

^§P = .006 compared with small size of infarction.

^‖P = .043 compared with fair prognosis.